Skip to content

Clinical trials

Phase 3 Narcolepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 3 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20044
20051
20141
20152
20161
20171
20201
20212
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals6
Cephalon5
Avadel2
Axsome Therapeutics, Inc.2
Alkermes, Inc.1
Harmony Biosciences Management, Inc.1
Orphan Medical1
Suven Life Sciences Limited1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy20
Disorders of Excessive Somnolence12
Cataplexy9
Sleep Apnea, Obstructive5
Fatigue2
Sleep Wake Disorders2
Chronobiology Disorders1
Idiopathic Hypersomnia1
Parasomnias1
Sleep Apnea Syndromes1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.